임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
32건 표시
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
리드: 애브비
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
리드: 애브비
- 1상모집 중· Healthy VolunteerA Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants
리드: 애브비
- 1상모집 중· Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative DisorderEpcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders
협력: 애브비
- 1상모집 중· Non-Hodgkin LymphomaStudy of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
협력: 애브비
- 1상모집 중· Diffuse Large B-Cell LymphomaA Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
리드: 애브비
- 1상모집 중· Myelodysplastic Syndromes, de NovoVenetoclax Basket Trial for High Risk Hematologic Malignancies
협력: 애브비
- 1상모집 중· Acute Myeloid LeukemiaVenetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
협력: 애브비
- 1상모집 중· Non-Small Cell Lung CancerStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
리드: 애브비
- 1상모집 중· Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRuxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
협력: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.